Experience

Debiopharm

• Switzerland
• Pharmaceutical Manufacturing
• 300 - 400 Employee

• Early Commercial Development Manager Oncology

  • Aug 2020 - Present



Oncology Commercial Solutions (OCS) Ltd

• Leatherhead, England, United Kingdom

• Director

  • Nov 2019 - Dec 2021



Pfizer

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Brand Director (International Developed Markets)

  • May 2018 - Apr 2019

  Responsible for all aspects of Launch Readiness for ALK Lung Asset as well as long range valuations in both Lung and IO space

• Brand Director IDM

  • Sep 2016 - Apr 2018

  Acting IDM IO Team Leader for IO co-promote asset ensuring development of co-promote processes for Region and Countries and smooth running of co-promote, Sep 2016-June 2017Launch Readiness responsibilities for IO Lung and Renal indications and generation of Regional long range forecasts across multiple indications (NSCLC, RCC, Ovarian, Gastric, Bladder, and MCC), June 2017-April 2018

• European Brand Director

  • Jan 2011 - Aug 2016

  Strategic commercialisation input into ALK, EGFR and ROS-1 Lung Cancer assets including formation and leadership of Lung cross-functional team, assumption validation and long-range forecast generation, Opinion leader development and nurture, positioning and messaging.

• New Product Commercialisation Roles

  • Jul 2001 - Dec 2010

  Global Launch Readiness Director, including Wyeth integration activities and other BD valuations (2009-2010). Regional and Country New Product Commercialisation activities (oncology), (2006-2008) including secondment to RCC Team Leader role; UK New Product Development role including oncology (2004-2006); UK Celebrex Marketing role (2001-2004)



Bristol Myers Squibb

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Marketing

  • 1999 - Jul 2001